Početna › Sarkom mekih tkiva › Missouri
Kliničke studije za Sarkom mekih tkiva u državi Missouri
15 studija za Sarkom mekih tkiva traži sudionike na lokacijama u državi Missouri.
Gradovi u državi Missouri
Službeni tekst studije (engleski)
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Mercy Oncology and Hematology - Clayton-Clarkson, Ballwin
- Central Care Cancer Center - Bolivar, Bolivar
- Cox Cancer Center Branson, Branson
- i još 21
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 40 do 75 godina · Oba spola · Ažurirano 2. lis 2026. · NCT05334069A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
- Washington University School of Medicine in St. Louis, St Louis
U tijeku regrutacijaFaza 1/2
Do 25 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT04094610Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma
- Washington University School of Medicine, St Louis
- Siteman Cancer Center-South County, St Louis
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 4. ruj 2026. · NCT05711615Domatinostat With Sirolimus for Relapsed, Refractory Sarcoma and Osteosarcoma
- Washington University in St. Louis, St Louis
U tijeku regrutacijaFaza 1/2
Od 12 do 40 godina · Oba spola · Ažurirano 3. ruj 2026. · NCT07725380Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women
- Washington University School of Medicine, St Louis
U tijeku regrutacijaOpažajna studija
Od 18 do 50 godina · Žene · Ažurirano 2. ruj 2026. · NCT06904365IDOV-Immune for Advanced Solid Tumors
- Washington University School of Medicine, St Louis
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 5. kol 2026. · NCT06910657NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
- Washington University Medical Center, St Louis
U tijeku regrutacijaFaza 1/2
Do 30 godina · Oba spola · Ažurirano 3. kol 2026. · NCT06239272Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration
- Washington University in St. Louis, St Louis
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 28. srp 2026. · NCT04040205Phase 1a/b Study of ZL-6201 Safety, PK, and Preliminary Efficacy in Sarcoma and Selected Tumors
- Zai Lab Site 02005, St Louis
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 23. srp 2026. · NCT07374848Lead-212 PSV359 Therapy for Patients With Solid Tumors
- Saint Louis University, St Louis
U tijeku regrutacijaFaza 1/2
Od 18 do 90 godina · Oba spola · Ažurirano 6. srp 2026. · NCT06710756Integrated Cancer Repository for Cancer Research
- Saint Luke's Cancer Institute, East, Kansas City
- Saint Luke's Cancer Institute, Kansas City
- Saint Luke's Cancer Institute, Kansas City North, Kansas City
- i još 3
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 19 do 110 godina · Oba spola · Ažurirano 29. lip 2026. · NCT02012699Zanzalintinib Combined With Eribulin in Advanced Liposarcoma and Leiomyosarcoma
- Washington University School of Medicine, St Louis
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 3. lip 2026. · NCT06957431A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- Washington University Infusion Center Pharmacy, St Louis
U tijeku regrutacijaFaza 1/2
Od 12 godina i više · Oba spola · Ažurirano 27. svi 2026. · NCT03093116Propranolol for the Treatment of Kaposi Sarcoma in Adults
- Washington University School of Medicine, St Louis
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 6. tra 2026. · NCT06445166Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
- Washington University School of Medicine, St Louis
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 18 godina i više · Oba spola · Ažurirano 20. velj 2026. · NCT04354064Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.